BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38332747)

  • 1. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
    Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
    Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.
    Ziaei A; Lavery AM; Shao XM; Adams C; Casper TC; Rose J; Candee M; Weinstock-Guttman B; Aaen G; Harris Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Hart J; Waldman AT; Barcellos LF; Waubant E
    Mult Scler; 2022 Aug; 28(9):1330-1339. PubMed ID: 35000467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
    Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
    Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
    Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
    Jacobs BM; Giovannoni G; Cuzick J; Dobson R
    Mult Scler; 2020 Oct; 26(11):1281-1297. PubMed ID: 32202208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
    Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common viruses associated with lower pediatric multiple sclerosis risk.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Chabas D; Strober J; McDonald J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; Oksenberg JR; James JA;
    Neurology; 2011 Jun; 76(23):1989-95. PubMed ID: 21646624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in association of remote herpesvirus infections and pediatric MS.
    Nourbakhsh B; Rutatangwa A; Waltz M; Rensel M; Moodley M; Graves J; Casper TC; Waldman A; Belman A; Greenberg B; Goyal M; Harris Y; Kahn I; Lotze T; Mar S; Schreiner T; Aaen G; Hart J; Ness J; Rubin J; Tillema JM; Krupp L; Gorman M; Benson L; Rodriguez M; Chitnis T; Rose J; Candee M; Weinstock-Guttman B; Shao X; Barcellos L; James J; Waubant E;
    Ann Clin Transl Neurol; 2018 Oct; 5(10):1222-1228. PubMed ID: 30349857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study.
    Domínguez-Mozo MI; López-Lozano L; Pérez-Pérez S; García-Martínez Á; Torrejón MJ; Arroyo R; Álvarez-Lafuente R
    Front Immunol; 2022; 13():991662. PubMed ID: 36189297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis.
    Menegatti J; Schub D; Schäfer M; Grässer FA; Ruprecht K
    Eur J Immunol; 2021 Sep; 51(9):2348-2350. PubMed ID: 34019695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
    Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
    PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk factors for pediatric-onset multiple sclerosis.
    Gianfrancesco MA; Stridh P; Shao X; Rhead B; Graves JS; Chitnis T; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee M; Krupp L; Gorman M; Benson L; Rodriguez M; Mar S; Kahn I; Rose J; Roalstad S; Casper TC; Shen L; Quach H; Quach D; Hillert J; Hedstrom A; Olsson T; Kockum I; Alfredsson L; Schaefer C; Barcellos LF; Waubant E;
    Mult Scler; 2018 Dec; 24(14):1825-1834. PubMed ID: 28980494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.